Table 2:
Model A | Model B | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Non- Cancer Controls (n=441) | Persistent CRCD1 (n=60) | Non-Declining Survivors (n=147) | Persistent CRCD (n=60) | |||||||
Variable | Lasso Rank | Mean | SD | Mean | SD | Lasso Rank | Mean | SD | Mean | SD |
Category Fluency Total | 1 | 0.07 | 4.61 | −1.62 | 4.71 | 1 | 0.38 | 4.55 | −1.62 | 4.71 |
NAB List Learning Trial 3 | 2 | 0.26 | 1.90 | −0.45 | 1.95 | 5 | 0.18 | 1.82 | −0.45 | 1.95 |
NAB Driving Scenes | 3 | −1.79 | 7.05 | −3.88 | 6.88 | 3 | −1.16 | 7.61 | −3.88 | 6.88 |
NAB Digit Span Forward Total | 7 | 0.21 | 1.99 | −0.53 | 1.55 | 2 | 0.34 | 1.91 | −0.53 | 1.55 |
PCI Score Baseline | 9 | 61.08 | 21.39 | 68.20 | 14.87 | 4 | 61.41 | 21.41 | 68.20 | 14.87 |
TIADL Ingredients Can 2 Time2 | 10 | 0.02 | 12.41 | 2.50 | 9.07 | 8 | −0.54 | 13.40 | 2.50 | 9.07 |
FACIT-Fatigue | 4 | 1.26 | 7.99 | −2.02 | 8.90 | |||||
NAB List A Immediate Raw Score | 5 | 1.09 | 4.57 | −0.30 | 3.90 | |||||
COWAT A Intrusions2 | 6 | −0.10 | 0.74 | 0.75 | 6.80 | |||||
NAB List Learning Long Delay Forced Choice False Alarms2 | 8 | −0.55 | 2.68 | 0.10 | 2.30 | |||||
Trail Making Test B Time2 | 6 | −7.03 | 31.57 | 0.96 | 33.54 | |||||
NAB List Learning Long Delay Forced Choice Hits | 7 | 0.13 | 1.45 | 0.40 | 1.37 | |||||
NAB Figure Drawing Copy | 9 | −0.49 | 4.75 | 0.17 | 4.43 | |||||
Category Fluency Perseverations2 | 10 | 0.06 | 1.23 | −0.17 | 1.38 |
Shaded areas represent tests that were not top ranked for that model.
Persistent CRCD is defined as 3.7+ points decline on the FACT-Cog Perceived Cognitive Impairment (PCI) scale from pre-systemic therapy baseline to 12 months, with persistence to 24-months
Higher scores indicate worse performance
NAB = Neuropsychological Assessment Battery; PCI – Perceived Cognitive Impairment; TIADL = Timed Instrumental Activities of Daily Living; FACIT = Functional Assessment of Chronic Illness Therapy; COWAT = Controlled Oral Word Association Test; CRCD=cancer-related cognitive decline